NIOX Group (LON:NIOX) Issues Quarterly Earnings Results

NIOX Group (LON:NIOX – Get Free Report) released its earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%.

NIOX Group Price Performance

NIOX stock traded up GBX 0.80 during midday trading on Friday, reaching GBX 66.80. The company had a trading volume of 175,685 shares, compared to its average volume of 796,137. NIOX Group has a 1-year low of GBX 53.84 and a 1-year high of GBX 76. The stock has a 50 day moving average price of GBX 65.81 and a 200-day moving average price of GBX 61.71. The company has a debt-to-equity ratio of 1.06, a current ratio of 4.60 and a quick ratio of 1.94. The company has a market capitalization of £281.14 million, a price-to-earnings ratio of 40.73 and a beta of 0.92.

NIOX Group Company Profile

(Get Free Report)

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.

Further Reading

Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.